JP2024545695A5 - - Google Patents
Info
- Publication number
- JP2024545695A5 JP2024545695A5 JP2024537165A JP2024537165A JP2024545695A5 JP 2024545695 A5 JP2024545695 A5 JP 2024545695A5 JP 2024537165 A JP2024537165 A JP 2024537165A JP 2024537165 A JP2024537165 A JP 2024537165A JP 2024545695 A5 JP2024545695 A5 JP 2024545695A5
- Authority
- JP
- Japan
- Prior art keywords
- free acid
- cancer
- crystalline free
- crystalline
- acid compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293183P | 2021-12-23 | 2021-12-23 | |
| US63/293,183 | 2021-12-23 | ||
| PCT/US2022/053842 WO2023122289A1 (en) | 2021-12-23 | 2022-12-22 | Crystalline salt form of ep4 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545695A JP2024545695A (ja) | 2024-12-10 |
| JP2024545695A5 true JP2024545695A5 (enExample) | 2025-12-17 |
Family
ID=85222399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537165A Pending JP2024545695A (ja) | 2021-12-23 | 2022-12-22 | Ｅｐ４アンタゴニストの結晶塩形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250051285A1 (enExample) |
| EP (1) | EP4452949A1 (enExample) |
| JP (1) | JP2024545695A (enExample) |
| KR (1) | KR20240124927A (enExample) |
| CN (1) | CN118414328A (enExample) |
| CA (1) | CA3242277A1 (enExample) |
| WO (1) | WO2023122289A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202211232D0 (en) | 2022-08-02 | 2022-09-14 | Heptares Therapeutics Ltd | Prostaglandin EP4 receptor agonist compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3061751A1 (en) | 2010-09-21 | 2016-08-31 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition |
-
2022
- 2022-12-22 CA CA3242277A patent/CA3242277A1/en active Pending
- 2022-12-22 US US18/719,032 patent/US20250051285A1/en active Pending
- 2022-12-22 EP EP22856901.8A patent/EP4452949A1/en active Pending
- 2022-12-22 JP JP2024537165A patent/JP2024545695A/ja active Pending
- 2022-12-22 KR KR1020247020974A patent/KR20240124927A/ko active Pending
- 2022-12-22 WO PCT/US2022/053842 patent/WO2023122289A1/en not_active Ceased
- 2022-12-22 CN CN202280084209.3A patent/CN118414328A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025176008A5 (enExample) | ||
| JP5064024B2 (ja) | イマチニブの製造方法、及び該方法により製造されたイマチニブ | |
| JP2022186995A5 (enExample) | ||
| WO2003037881A1 (en) | α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE | |
| CN101243066B (zh) | 甲磺酸伊马替尼的δ和ε晶形 | |
| CA2539909A1 (en) | 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes | |
| JP4142621B2 (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| JP5094721B2 (ja) | Ｎ−フェニル−２−ピリミジン−アミン誘導体及びそれの調製のための工程 | |
| JP2014074067A (ja) | メシル酸イマチニブのｆ、ｇ、ｈ、ｉおよびｋ結晶形 | |
| JP2023083528A5 (enExample) | ||
| CN114716496B (zh) | 氟维司群衍生物及氟维司群衍生物制备方法和应用 | |
| JP2012507496A (ja) | レナリドマイドの結晶形およびその調製方法 | |
| JP2022551525A5 (enExample) | ||
| US20130281451A1 (en) | Indolin-2-one derivatives as protein kinase inhibitors | |
| JP2021535111A5 (enExample) | ||
| JP2023530786A5 (enExample) | ||
| JP2023517729A5 (enExample) | ||
| WO2012059001A1 (zh) | 咪唑衍生物、制备方法及用途 | |
| JP2004530706A (ja) | 純粋な結晶形態にある５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニル及び合成方法 | |
| JP2020512975A5 (enExample) | ||
| WO2018133533A1 (zh) | 孟鲁司特钠中间体及其制备方法和应用 | |
| JP2023548605A5 (enExample) | ||
| JPH02258760A (ja) | チオホルムアミド誘導体 | |
| JP3558152B2 (ja) | Ｎ−ヒドロキシ尿素誘導体 | |
| JP2024545695A (ja) | Ｅｐ４アンタゴニストの結晶塩形態 |